Odrich Marc has filed 6 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 84200 shares of LENZ Therapeutics, Inc. ($LENZ) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | LENZ Therapeutics, Inc. | $LENZ | Odrich Marc | Chief Medical Officer | A | Stock Option (right to buy) | 84200 | $0.00 | 84,200.0000 | 31,289,969 | 9999.99% | 0.27% |
| Jan. 2, 2026 | LENZ Therapeutics, Inc. | $LENZ | Odrich Marc | Chief Medical Officer | A | Restricted Stock Unit | 14000 | $0.00 | 14,000.0000 | 31,289,969 | 9999.99% | 0.04% |
| Jan. 9, 2025 | LENZ Therapeutics, Inc. | $LENZ | Odrich Marc | Chief Medical Officer | A | Stock Option (right to buy) | 80100 | $0.00 | 80,100.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Odrich Marc | Chief Medical Officer | A | Common Stock | 99599 | $0.00 | 99,599.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Odrich Marc | Chief Medical Officer | A | Stock Option (right to buy) | 66472 | $0.00 | 66,472.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Odrich Marc | Chief Medical Officer | A | Stock Option (right to buy) | 105000 | $0.00 | 105,000.0000 | 0 | 9999.99% | 0.00% |